Curcumin pre-treatment may protect against mitochondrial damage in LRRK2-mutant Parkinson's disease and healthy control fibroblasts
Open Access
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 27, 101035
Abstract
No abstract availableKeywords
Funding Information
- Faculty of Science, Medicine and Health
- National Research Foundation (106052, 120719, 96072)
- South African Medical Research Council
- Universiteit Stellenbosch
This publication has 14 references indexed in Scilit:
- Curcumin Rescues a PINK1 Knock Down SH-SY5Y Cellular Model of Parkinson’s Disease from Mitochondrial Dysfunction and Cell DeathMolecular Neurobiology, 2016
- Mitochondrial Biology and Neurological DiseasesCurrent Neuropharmacology, 2016
- Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase InhibitionMolecular Neurobiology, 2015
- Mutant LRRK2 Elicits Calcium Imbalance and Depletion of Dendritic Mitochondria in NeuronsThe American Journal of Pathology, 2013
- The Role of Oxidative Stress in Parkinson's DiseaseJournal of Parkinson’s Disease, 2013
- Paraquat induces lung alveolar epithelial cell apoptosis via Nrf-2-regulated mitochondrial dysfunction and ER stressArchives of Toxicology, 2012
- Paraquat and Parkinson's diseaseCell Death & Differentiation, 2010
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control studyThe Lancet Neurology, 2008
- Bioavailability of Curcumin: Problems and PromisesMolecular Pharmaceutics, 2007
- Redox cycling of the herbicide paraquat in microglial culturesMolecular Brain Research, 2005